Previous Article | Next Article ![]()
Journal of Clinical Microbiology, June 2000, p. 2065-2075, Vol. 38, No. 6
Federal Research Centre for Virus Diseases of
Animals, D-72076 Tübingen,1 and
Institute for Hygiene and Infectious Diseases of Animals,
D-35392 Giessen,2 Germany, and Virology
Unit, Department of Infectious Diseases and Immunology, Veterinary
Faculty, Utrecht University, 3584 CL Utrecht, The
Netherlands3
Received 7 September 1999/Returned for modification 29 December
1999/Accepted 25 March 2000
We recently developed a highly effective immunization procedure for
the generation of monoclonal antibodies (MAbs) directed against the
porcine reproductive and respiratory syndrome virus (E. Weiland, M. Wieczorek-Krohmer, D. Kohl, K. K. Conzelmann, and F. Weiland, Vet.
Microbiol. 66:171-186, 1999). The same method was used to produce a
panel of 16 MAbs specific for the equine arteritis virus (EAV). Ten
MAbs were directed against the EAV nucleocapsid (N) protein, and five
MAbs recognized the major viral envelope glycoprotein (GL).
Two of the EAV GL-specific MAbs and one antibody of unknown
specificity neutralized virus infectivity. A comparison of the
reactivities of the MAbs with 1 U.S. and 22 newly obtained European
field isolates of EAV demonstrated that all N-specific MAbs, the three
nonneutralizing anti-GL MAbs, and the weakest neutralizing
MAb (MAb E7/d15-c9) recognized conserved epitopes. In contrast, the
two MAbs with the highest neutralization titers bound to 17 of 23 (MAb
E6/A3) and 10 of 23 (MAb E7/d15-c1) of the field isolates. Ten of the
virus isolates reacted with only one of these two MAbs, indicating that
they recognized different epitopes. The GL-specific
MAbs and the strongly neutralizing MAb of unknown specificity (MAb
E6/A3) were used for the selection of neutralization-resistant (NR)
virus variants. The observation that the E6/A3-specific NR virus
variants were neutralized by MAb E7/d15-c1 and that MAb E6/A3 blocked
the infectivity of the E7/d15-c1-specific NR escape mutant confirmed
that these antibodies reacted with distinct antigenic sites.
Immunoelectron microscopy revealed for the first time that the
antigenic determinants recognized by the anti-GL MAbs were
localized on the virion surface. Surprisingly, although the
immunofluorescence signal obtained with the neutralizing antibodies was
relatively weak, they mediated binding of about three times as much
gold granules to the viral envelope than the nonneutralizing
anti-GL MAbs.
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Monoclonal Antibodies Directed against Conserved
Epitopes on the Nucleocapsid Protein and the Major Envelope
Glycoprotein of Equine Arteritis Virus
*
Corresponding author. Mailing address: Federal Research
Centre for Virus Diseases of Animals, Paul-Ehrlich-Strasse 28, D-72076 Tübingen, Germany. Phone: 49-7071-967204. Fax: 49-7071-967105. E-mail: E.Weiland{at}tue.bfav.de.
Present address: Gene Therapy Section, Department of Molecular Cell
Biology, Leiden University Medical Center, 2333 AL Leiden, The Netherlands.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»